Ethical considerations in balancing dermatologic symptom control and systemic risks of polypharmacy in geriatrics

Janice Kim; Tarek Zieneldien; Sophia Ma; Isabella J Tan; Jane M Grant-Kels

doi:10.1016/j.jaad.2025.10.137

Ethical considerations in balancing dermatologic symptom control and systemic risks of polypharmacy in geriatrics

J Am Acad Dermatol. 2026 May;94(5):1605-1606. doi: 10.1016/j.jaad.2025.10.137. Epub 2025 Nov 1.

Authors

Janice Kim¹, Tarek Zieneldien², Sophia Ma², Isabella J Tan³, Jane M Grant-Kels⁴

Affiliations

¹ College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan.
² Johns Hopkins University School of Medicine, Baltimore, Maryland.
³ Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
⁴ Department of Dermatology, University of Connecticut, Farmington, Connecticut; Department of Dermatology, University of Florida, Gainesville, Florida. Electronic address: grant@uchc.edu.

PMID: 41183710
DOI: 10.1016/j.jaad.2025.10.137

No abstract available

Keywords: Polypharmacy; deprescribing; dermatology ethics; drug–drug interactions; ethical prescribing; financial toxicity; geriatric dermatology; health equity; interdisciplinary care; medication burden; multimorbidity.

Publication types

Letter